Last reviewed · How we verify
NCT05509881: CONDOR
Continuous Glucose Monitoring in Dialysis Patients to Overcome Dysglycemia Trial
NA trial testing Continuous glucose monitoring (CGM) in Hemodialysis in 122 participants. Status unknown.
31 January 2026
Quick facts
| Lead sponsor | University of California, Irvine |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 122 |
| Start date | 12 December 2023 |
| Primary completion | 31 January 2026 |
| Estimated completion | 31 January 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Continuous glucose monitoring (CGM)
- Usual care (Self-monitored blood glucose)
Conditions studied
- Hemodialysis — all drugs for Hemodialysis →
- Diabete Mellitus — all drugs for Diabete Mellitus →
- Continuous Glucose Monitoring — all drugs for Continuous Glucose Monitoring →
Sponsor
University of California, Irvine
Who can join
Adults 18 to 99, any sex, with Hemodialysis or Diabete Mellitus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This randomized controlled trial will investigate whether use of continuous glucose monitoring (CGM) vs. usual care with self-monitored blood glucose 1) enhances glycemic control, 2) reduces hypoglycemia risk, and 3) improves quality of life, diabetes distress, and fear of hypoglycemia in hemodialysis patients with diabetes mellitus.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Diabetes technology in people with diabetes and advanced chronic kidney disease.
Galindo RJ, Soliman D, Cherñavvsky D, Rhee CM. · · 2024 · cited 10× · PMID 39112642 · DOI 10.1007/s00125-024-06244-y
Verify or expand the search:
- PubMed search for NCT05509881
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Continuous glucose monitoring (CGM)
Trials testing the same drug.
- NCT05741489 — Continuous Glucose Monitoring in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes · NA · completed
- NCT04605497 — Time-in-range Using Continuous Glucose Monitoring Management of Gestational Diabetes Mellitus · NA · completed
Other recruiting trials for Hemodialysis
Currently open trials in the same condition.
- NCT07278973 — Hemodiafiltration Versus Hemodialysis in Older People · NA · recruiting
- NCT07438925 — Copeptin Concentration Measured in Plasma Samples and Intradialytic Blood Pressure Variation · active not recruiting
- NCT07234890 — Study to Evaluate the Effects of AV-001 on HD-induced Brain Injury. · Phase 2 · recruiting
- NCT07512895 — The Effect of Progressive Muscle Relaxation Exercises on Depression and Fatigue in Patients Receiving Hemodialysis Treat · NA · recruiting
- NCT07076888 — Aerobic Exercises and Hemodialysis Patients · NA · recruiting
Other University of California, Irvine trials
Trials by the same sponsor.
- NCT06952725 — Chatbot for Online Support Groups to Treat Tobacco Addiction · NA · not yet recruiting
- NCT07167862 — Optimizing Preeclampsia Postpartum With Point-of-care Ultrasound · Phase 4 · not yet recruiting
- NCT07527325 — Fianlimab&Cemiplimab as TotalNeoadj The (TNT) ForMelanoma · Phase 2 · not yet recruiting
- NCT07391891 — Musical Mindfulness for Pain in the ED Waiting Room · NA · not yet recruiting
- NCT07209917 — Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05509881 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of California, Irvine
- Last refreshed: 28 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05509881.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing